Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis

Archives of Gynecology and Obstetrics

Volumn 274, Issue 3, 2006, Pages 133-137

  Verit, Fatma Ferda ^a   Geyikli, Iclal ^a   Yazgan, Pelin ^a   Celik, Ahmet ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bone mineral density; Bone turnover markers; Postmenopausal osteoporosis; Prolidase

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PROLINE DIPEPTIDASE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; STATISTICAL SIGNIFICANCE;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; COLLAGEN TYPE I; CREATININE; DENSITOMETRY, X-RAY; DIPEPTIDASES; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; POSTMENOPAUSE;

EID: 33646891526     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0148-9     Document Type: Article

References (17)

1. Brincat MP (2000) Hormone replacement therapy and the skin. Maturitas 35:107-117
2. Consensus Development Statement (1997) Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 7:1-6
3. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES (2002) Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 35:263-268
4. Felsenberg D, Boonen S (2005) The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 27:1-11
5. Gualicka A, Wolczynski S, Anchim T, Surazynski A, Lesniewicz R, Palka J (2001) Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta. Eur J Biochem 268:2172-2178
6. Kao WH, Kammerer CM, Schneider JL, Bauer RL, Mitchell BD (2003) Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res 34:399-406
7. Karna E, Miltyk W, Wolczynski S, Palka JA (2001) The potential mechanism for glutamine-induced collagen biosynthesis in cultured human skin fibroblasts. Comp Biochem Physiol 130:23-32
8. Kir ZO, Oner P, Iyidogan YO, Turkmen S, Kocak H, Koser M, Kucucuk SO (2003) Serum prolidase I activity and some bone metabolic markers in patients with breast cancer: in relation to menopausal status. Clin Biochem 36:289-294
9. Muszynska A, Wolczynski S, Palka J (2001) The mechanism for anthracycline-induced inhibition of collagen biosynthesis. Eur J Pharmacol 411:17-25
10. Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A (1984) Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 302:211-215
11. Namiduru ES, Ozdemir Y, Kutlar I, Ersoy U (2001) A study of prolidase in mothers, their newborn babies and in non-pregnant controls. Arch Gynecol Obstet 265:73-75
12. Oner P, Gurdol F, Oner-Iyidon Y, Kolanci C, Buyukozturk S (1999) Evaluation of the effect of low-dose oral theophylline therapy on some bone turnover markers and serum prolidase I activity in mild asthmatics. Pharmacol Res 40:189-193
13. Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone 19:479-484
14. Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA (2000) The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 68:35-41
15. Sumino H, Ichikawa S, Abe M, Endo Y, Nakajima Y, Minegishi T, Ishikawa O, Kurabayashi M (2004) Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women. Endocr J 51:159-164
16. Surazynski A, Jarzabek K, Haczynski J, Laudanski P, Palka J, Wolczynski S (2003) Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Mol Med 12:803-809
17. Wolczynski S, Surazynski A, Swiatecka J, Palka J (2001) Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells. Gynecol Endocrinol 15:225-233